Evidence map›Paper›PMID 41495849›Full record

ArticleImplementation science : IS2026

A cluster randomised controlled trial, process and economic evaluation of two large-scale quality improvement interventions embedded with a national clinical audit to improve the care for young adults with type 2 diabetes (EQUIPD2): study protocol.

Michael Sykes, Bethan Copsey, Tracy Finch, Adam Martin, Alice Hankin, Melissa Girling, Elaine O'Halloran, Ruth Medcalf-Bell, Bryony Dawkins, Jenny McSharry and 10 more

Abstract readClinical Trial Protocol
In one paragraph

Article in Implementation science : IS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Michael SykesNorthumbria University, Newcastle upon Tyne, UK. Michael.sykes@Northumbria.ac.uk.ORCID 0000-0002-2039-7397
Bethan CopseyUniversity of Leeds, Leeds, UK.
Tracy FinchNorthumbria University, Newcastle upon Tyne, UK.
Adam MartinUniversity of Leeds, Leeds, UK.
Alice HankinUniversity of Leeds, Leeds, UK.
Melissa GirlingNorthumbria University, Newcastle upon Tyne, UK.
Elaine O'HalloranNorthumbria University, Newcastle upon Tyne, UK.
Ruth Medcalf-BellNorthumbria University, Newcastle upon Tyne, UK.
Bryony DawkinsUniversity of Leeds, Leeds, UK.
Jenny McSharryUniversity of Galway, Galway, Ireland.
Eimear MorrisseyUniversity of Galway, Galway, Ireland.
Shivani MisraImperial College London, London, UK.
David GableImperial College Healthcare NHS Foundation Trust, London, England.
Garry TanNational Diabetes Audit, London, UK.
Alex BerryDiabetes UK, London, UK.
Kayleigh SteeleExpert By Experience, London, UK.
Florence DayUniversity of Leeds, Leeds, UK.
Lauren MoreauUniversity of Leeds, Leeds, UK.
Rosemary DeweyNHS West Yorkshire Integrated Care Board, Wakefield, UK.
Robbie FoyUniversity of Leeds, Leeds, UK.

Funding

Health Services Research Programme 168871
6 · The paper itself

Abstract

backgroundYoung adults (18-39 years) with type 2 diabetes have an increased loss of life expectancy and a greater risk of complications such as retinopathy, sexual health problems and foot disease than people diagnosed with type 2 diabetes later in life. Globally, there are increasing numbers of young adults with type 2 diabetes. Evidence describes both care (for example, prescribing) and improvement practices (for example, case management) that improve outcomes for people with type 2 diabetes. The National Diabetes Audit (NDA) provides feedback describing variation in both care and outcomes in young adults. Feedback facilitation can increase the effectiveness of audit feedback. Working collaboratively between researchers, audit providers, patients, clinicians and policy-makers, we have developed two feedback facilitation interventions deliverable at scale across England. We will evaluate whether theory-informed virtual educational materials with email support (low-intensity intervention) and / or virtual workshops (medium-intensity intervention) improve outcomes for young adults with type 2 diabetes.

methodsAn efficient, pragmatic cluster randomised controlled trial using routine data with a theory-informed process and economic evaluation. The interventions will be delivered alongside the NDA to primary care networks (small groups of general practices) across England. Our primary outcome will be HbA1c level at 16-months post-randomisation in young adults with type 2 diabetes and baseline HbA1c ≥ 58 mmol/mol. Secondary outcomes assess the proportion with an HbA1c below recommended thresholds, prescription consistent with recommendations and delivery of recommended care processes. We will investigate impacts on equity. We will explore implementation, engagement and fidelity through interviews, observations, documentary analysis and surveys. An economic evaluation will estimate cost-effectiveness and budget impact. DISCUSSION: Our study embeds a further evaluation within the NDA, strengthening its role as a national diabetes learning health system. Our findings will have implications for intervention providers and funders seeking improvement in care and outcomes, and for our understanding of large-scale implementation strategies.

trial registrationISRCTN 52205353 Registered 12 March 2025.  https://www.isrctn.com/ISRCTN52205353 .

Indexed as

Clinical AuditDiabetes Mellitus, Type 2Quality ImprovementAdolescentAdultCost-Benefit AnalysisEnglandHumansImplementation ScienceMaleRandomized Controlled Trials as TopicYoung AdultAudit and feedbackDiabetesLearning health systemQuality improvementRandomised controlled trial

Identifiers

PMID41495849
PMCPMC12870161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.